Cannabinoids and Health- from supplements to medicines

Subpage image
Loading

Cannabinoids and Health- from supplements to medicines

06 Oct 2019
PUBLIC HEALTH & WELLBEING THEATRE
This talk will overview: '- The endocannabinoid system as a pharmacological target, '- Clinical trial evidence base for key indications, '- Current CBD supplement and MedCan prescribing regulatory frameworks, '- Key messages from GL online CBD pharmacist training course, '- Overview of available MedCan prescribing recommendations (HPRA, NICE, others). (GLs roles or aims in relevant areas highlighted throughout)
Speakers
David Gibson, Chief Scientific Officer - GreenLight Pharmaceuticals Ltd.

In association with

POfizer

Supported by

  • AIM
  • General Pharmaceutical Council
  • NHS
  • NHS England
  • National Pharmacy Association - NPA
  • PCPA
  • PSNC
  • Bayer and Bayer
  • Pharmacists Defence Association
  • Cegedimix
  • Day Lewis

Education Partners

  • Day Lewis
  • ECG Training
  • Gama Healthcare
  • GSK
  • NPA
  • NHS
  • Omron
  • Parkinsons
  • PDA
  • PSNC
  • Rx Advisor
  • Real World Analytics
  • Royal Pharmaceutical Society
  • Scope Group
  • Soar Beyond
  • Velresco
  • Well Pharmacy
  • Solgar
  • Infirst
  • Invatech
  • Numark
  • AIM
  • Cegedim
  • JUUL Labs
  • Seqirus
  • BD
  • msd
  • CPPE
  • HEE
  • Centered Solutions

Sponsored by

  • National Pharmacy Association
  • GSK
  • NHS
  • NHS England
  • CPPE
  • Pfizer
  • Bollore
  • EMIS
  • C+D
  • Numark
  • RB
  • Alphega

Charity Partner

  • Arthritis Research
  • Pharmacist Support
  • Parkinsons
  • Pancreatuc Cancer Action

Official Media Partner


CIG

Official Publications

  • Pharmacy Magazine
  • Independent Community Pharmacist
  • Training Matters
  • P3
  • The Pharmacy Network

Digital Media Partner


C+D

Natural Education Partner

Natural Pharmacy Business

Media partners

  • Pharmacy Talk
  • Guidelines In Practice
  • Pharmacy In Focus
  • Pharmacy Mentor
  • Pharmacy Business
  • Scottish Pharmacist
  • Pharmdata